NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

<p>Abstract</p> <p>Background</p> <p>We recently examined the distribution of abdominal fat, dietary intake and biochemical data in patients with nonalcoholic fatty liver disease (NAFLD) and found that non-obese NAFLD patients did not necessarily exhibit insulin resista...

Full description

Bibliographic Details
Main Authors: Kotoh Kazuhiro, Kato Masaki, Kohjima Motoyuki, Machida Kazuyuki, Enjoji Munechika, Matsunaga Kazuhisa, Nakashima Manabu, Nakamuta Makoto
Format: Article
Language:English
Published: BMC 2010-03-01
Series:Lipids in Health and Disease
Online Access:http://www.lipidworld.com/content/9/1/29

Internet

http://www.lipidworld.com/content/9/1/29

Similar Items